RIPK3 interacts with MAVS to regulate type I IFN-mediated immunity to Influenza A virus infection

PLoS Pathogens

Volumn 13, Issue 4, 2017, Pages

  Downey, Jeffrey ^a   Pernet, Erwan ^a   Coulombe, François ^a   Allard, Benoit ^a   Meunier, Isabelle ^a   Jaworska, Joanna ^a   Qureshi, Salman ^a   Vinh, Donald C ^a   Martin, James G ^a   Joubert, Philippe ^b   Divangahi, Maziar ^a  

^a MCGILL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERFERON; LACTATE DEHYDROGENASE; PROTEIN KINASE R; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING SERINE THREONINE PROTEIN KINASE 3; RECOMBINANT BETA INTERFERON; UNCLASSIFIED DRUG; BETA INTERFERON; IPS-1 PROTEIN, MOUSE; PROTEIN BINDING; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLUENZA A; INFLUENZA A VIRUS; LUNG FUNCTION; MACROPHAGE; MORBIDITY; MORTALITY; MOUSE; NECROPTOSIS; NONHUMAN; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; VIRUS IMMUNITY; VIRUS LOAD; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; INFLUENZA; METABOLISM; PHYSIOLOGY; VIROLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERON-BETA; MACROPHAGES; MICE; MICE, INBRED C57BL; PROTEIN BINDING; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 85018256712     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006326     Document Type: Article

References (52)

1. Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, Morii E, et al. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity. 2007;27(2):240–52. doi: 10.1016/j.immuni.2007.07.013 17723216
2. Wang J, Nikrad MP, Travanty EA, Zhou B, Phang T, Gao B, et al. Innate immune response of human alveolar macrophages during influenza A infection. PLoS One. 2012;7(3):e29879. Epub 2012 Mar 2. doi: 10.1371/journal.pone.0029879 22396727
3. Goritzka M, Makris S, Kausar F, Durant LR, Pereira C, Kumagai Y, et al. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J Exp Med. 2015;212(5):699–714. Epub 2015 Apr 20. doi: 10.1084/jem.20140825 25897172
4. Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science. 2015;347(6227):aaa2630. doi: 10.1126/science.aaa2630 25636800
5. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, Archer DR, et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity. 2000;13(1):129–41. 10933401
6. Schulz O, Pichlmair A, Rehwinkel J, Rogers NC, Scheuner D, Kato H, et al. Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe. 2010;7(5):354–61. doi: 10.1016/j.chom.2010.04.007 20478537
7. Schneider C, Nobs SP, Heer AK, Kurrer M, Klinke G, van Rooijen N, et al. Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog. 2014;10(4):e1004053. PubMed Central PMCID: PMCPMC3974877. doi: 10.1371/journal.ppat.1004053 24699679
8. Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013;38(4):792–804. doi: 10.1016/j.immuni.2013.04.004 23601688
9. Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD, CCR2+ Monocyte-Derived Dendritic Cells and Exudate Macrophages Produce Influenza-Induced Pulmonary Immune Pathology and Mortality. The Journal of Immunology. 2008;180(4):2562–72. 18250467
10. Coulombe F, Jaworska J, Verway M, Tzelepis F, Massoud A, Gillard J, et al. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages. Immunity. 2014;40(4):554–68. Epub 2014 Apr 10. doi: 10.1016/j.immuni.2014.02.013 24726877
11. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat Med. 2001;7(12):1306–12. doi: 10.1038/nm1201-1306 11726970
12. McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe. 2007;2(4):240–9. PubMed Central PMCID: PMCPMC2083255. doi: 10.1016/j.chom.2007.09.001 18005742
13. Jaworska J, Coulombe F, Downey J, Tzelepis F, Shalaby K, Tattoli I, et al. NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein. Proc Natl Acad Sci U S A. 2014;111(20):E2110–9. Epub 2014 May 5. doi: 10.1073/pnas.1322118111 24799673
14. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 2009;137(6):1112–23. doi: 10.1016/j.cell.2009.05.037 19524513
15. Upton JW, Kaiser WJ, Mocarski ES, Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe. 2010;7(4):302–13. doi: 10.1016/j.chom.2010.03.006 20413098
16. Nogusa S, Thapa RJ, Dillon CP, Liedmann S, Oguin TH, 3rdIngram JP, et al. RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus. Cell Host Microbe. 2016;20(1):13–24. PubMed Central PMCID: PMCPMC5026823. doi: 10.1016/j.chom.2016.05.011 27321907
17. Vince JE, Wong WW, Gentle I, Lawlor KE, Allam R, O'Reilly L, et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity. 2012;36(2):215–27. doi: 10.1016/j.immuni.2012.01.012 22365665
18. Moriwaki K, Balaji S, McQuade T, Malhotra N, Kang J, Chan FK, The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. Immunity. 2014;41(4):567–78. doi: 10.1016/j.immuni.2014.09.016 25367573
19. England H, Summersgill HR, Edye ME, Rothwell NJ, Brough D, Release of interleukin-1alpha or interleukin-1beta depends on mechanism of cell death. J Biol Chem. 2014;289(23):15942–50. Epub 2014 Apr 30. doi: 10.1074/jbc.M114.557561 24790078
20. Cullen SP, Kearney CJ, Clancy DM, Martin SJ, Diverse Activators of the NLRP3 Inflammasome Promote IL-1beta Secretion by Triggering Necrosis. Cell Reports. 2015;11(10):1535–48. Epub 2015 May 28. doi: 10.1016/j.celrep.2015.05.003 26027935
21. Christofferson DE, Li Y, Hitomi J, Zhou W, Upperman C, Zhu H, et al. A novel role for RIP1 kinase in mediating TNFalpha production. Cell Death Dis. 2012;3:e320. PubMed Central PMCID: PMCPMC3388236. doi: 10.1038/cddis.2012.64 22695613
22. Nogusa S, Slifker MJ, Ingram JP, Thapa RJ, Balachandran S, RIPK3 Is Largely Dispensable for RIG-I-Like Receptor- and Type I Interferon-Driven Transcriptional Responses to Influenza A Virus in Murine Fibroblasts. PLoS One. 2016;11(7):e0158774. PubMed Central PMCID: PMCPMC4938532. doi: 10.1371/journal.pone.0158774 27391363
23. Seo SU, Kwon HJ, Ko HJ, Byun YH, Seong BL, Uematsu S, et al. Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog. 2011;7(2):e1001304. PubMed Central PMCID: PMCPMC3044702. doi: 10.1371/journal.ppat.1001304 21383977
24. McComb S, Cessford E, Alturki NA, Joseph J, Shutinoski B, Startek JB, et al. Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages. Proc Natl Acad Sci U S A. 2014;111(31):E3206–13. PubMed Central PMCID: PMCPMC4128105. doi: 10.1073/pnas.1407068111 25049377
25. Williams BR, Signal integration via PKR. Sci STKE. 2001;2001(89):re2. doi: 10.1126/stke.2001.89.re2 11752661
26. Barry G, Breakwell L, Fragkoudis R, Attarzadeh-Yazdi G, Rodriguez-Andres J, Kohl A, et al. PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response. Journal of General Virology. 2009;90(Pt 6):1382–91. Epub 2009 Mar 4. doi: 10.1099/vir.0.007336-0 19264662
27. McAllister CS, Taghavi N, Samuel CE, Protein kinase PKR amplification of interferon beta induction occurs through initiation factor eIF-2alpha-mediated translational control. J Biol Chem. 2012;287(43):36384–92. doi: 10.1074/jbc.M112.390039 22948139
28. Pasparakis M, Vandenabeele P, Necroptosis and its role in inflammation. Nature. 2015;517(7534):311–20. doi: 10.1038/nature14191 25592536
29. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature. 2011;471(7338):368–72. PubMed Central PMCID: PMCPMC3060292. doi: 10.1038/nature09857 21368762
30. Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, Quarato G, Gurung P, et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell. 2014;157(5):1189–202. PubMed Central PMCID: PMCPMC4068710. doi: 10.1016/j.cell.2014.04.018 24813850
31. Wang X, Li Y, Liu S, Yu X, Li L, Shi C, et al. Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense. Proc Natl Acad Sci U S A. 2014;111(43):15438–43. Epub 2014 Oct 14. doi: 10.1073/pnas.1412767111 25316792
32. Rodrigue-Gervais IG, Labbe K, Dagenais M, Dupaul-Chicoine J, Champagne C, Morizot A, et al. Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell Host Microbe. 2014;15(1):23–35. doi: 10.1016/j.chom.2013.12.003 24439895
33. Wang X, Jiang W, Yan Y, Gong T, Han J, Tian Z, et al. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat Immunol. 2014;15(12):1126–33. Epub 2014 Oct 19. s%20Library/Library.papers3/Articles/2014/Wang/Nature%20Publishing%20Group%202014%20Wang.pdf. doi: 10.1038/ni.3015 25326752
34. Thomas PG, Dash P, Aldridge JR, Jr.Ellebedy AH, Reynolds C, Funk AJ, et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity. 2009;30(4):566–75. Epub 2009 Apr 9. doi: 10.1016/j.immuni.2009.02.006 19362023
35. Lu JV, Weist BM, van Raam BJ, Marro BS, Nguyen LV, Srinivas P, et al. Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A. 2011;108(37):15312–7. Epub 2011 Aug 29. doi: 10.1073/pnas.1102779108 21876153
36. Ch'en IL, Tsau JS, Molkentin JD, Komatsu M, Hedrick SM, Mechanisms of necroptosis in T cells. J Exp Med. 2011;208(4):633–41. Epub 2011 Mar 14. doi: 10.1084/jem.20110251 21402742
37. Weng D, Marty-Roix R, Ganesan S, Proulx MK, Vladimer GI, Kaiser WJ, et al. Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death. Proc Natl Acad Sci U S A. 2014;111(20):7391–6. Epub 2014 May 5. doi: 10.1073/pnas.1403477111 24799678
38. Balachandran S, Thomas E, Barber GN, A FADD-dependent innate immune mechanism in mammalian cells. Nature. 2004;432(7015):401–5. doi: 10.1038/nature03124 15549108
39. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M, et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol. 2004;5(5):503–7. doi: 10.1038/ni1061 15064760
40. Cusson-Hermance N, Khurana S, Lee TH, Fitzgerald KA, Kelliher MA, Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem. 2005;280(44):36560–6. doi: 10.1074/jbc.M506831200 16115877
41. Hyun J, Ramos JC, Toomey N, Balachandran S, Lavorgna A, Harhaj E, et al. Oncogenic human T-cell lymphotropic virus type 1 tax suppression of primary innate immune signaling pathways. J Virol. 2015;89(9):4880–93. Epub 2015 Feb 18. doi: 10.1128/JVI.02493-14 25694597
42. Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J, et al. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity. 2008;28(5):651–61. Epub 2008 Apr 24. doi: 10.1016/j.immuni.2008.03.013 18439848
43. Rajput A, Kovalenko A, Bogdanov K, Yang SH, Kang TB, Kim JC, et al. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity. 2011;34(3):340–51. doi: 10.1016/j.immuni.2010.12.018 21419663
44. Wong WW, Vince JE, Lalaoui N, Lawlor KE, Chau D, Bankovacki A, et al. cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood. 2014;123(16):2562–72. Epub 2014 Feb 4. doi: 10.1182/blood-2013-06-510743 24497535
45. Hogner K, Wolff T, Pleschka S, Plog S, Gruber AD, Kalinke U, et al. Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 2013;9(2):e1003188. Epub 2013 Feb 28. doi: 10.1371/journal.ppat.1003188 23468627
46. Thapa RJ, Ingram JP, Ragan KB, Nogusa S, Boyd DF, Benitez AA, et al. DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death. Cell Host Microbe. 2016;20(5):674–81. doi: 10.1016/j.chom.2016.09.014 27746097
47. Kuriakose T, Man SM, Malireddi RK, Karki R, Kesavardhana S, Place DE, et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol. 2016;1(2). PubMed Central PMCID: PMCPMC5131924.
48. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007;448(7152):501–5. doi: 10.1038/nature06013 17618271
49. Tzelepis F, Verway M, Daoud J, Gillard J, Hassani-Ardakani K, Dunn J, et al. Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection. J Clin Invest. 2015;125(2):752–68. PubMed Central PMCID: PMCPMC4319406. doi: 10.1172/JCI77014 25562320
50. Gaush CR, Smith TF, Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol. 1968;16(4):588–94. 5647517
51. Coulombe F, Fiola S, Akira S, Cormier Y, Gosselin J, Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection. PLoS One. 2012;7(5):e36734. Epub 2012 May 9. doi: 10.1371/journal.pone.0036734 22590599
52. Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem. 2013;288(43):31268–79. PubMed Central PMCID: PMCPMC3829437. doi: 10.1074/jbc.M113.462341 24019532